ask="15.00"
ask_size="1400"
average_daily_volume="168002"
bid="14.50"
bid_size="300"
book_value="3.69"
change="-0.55"
change_from_200_day_moving_average="1.44"
change_from_50_day_moving_average="-0.95"
change_from_52_week_high="-3.25"
change_From_52_week_low="7.47"
change_in_percent="-4.62%"
close="11.35"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.13"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-1.88"
ex_dividend_date="N/A"
float_shares="15630000"
high="11.85"
high_52_weeks="14.60"
last_trade_date="1/5/2017"
last_trade_price="11.35"
last_trade_size="2909"
last_trade_time="4:00pm"
low="11.30"
low_52_weeks="3.88"
market_capitalization="202.55M"
moving_average_200_day="9.91"
moving_average_50_day="12.30"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="28.25"
open="11.80"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+14.51%"
percent_change_from_50_day_moving_average="-7.76%"
percent_change_from_52_week_high="-22.26%"
percent_change_from_52_week_low="+192.53%"
previous_close="11.90"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.23"
price_per_sales="224.11"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="6.77"
stock_exchange="NCM"
symbol="STML"
volume="80819"
weeks_range_52="3.88 - 14.60"
